Skip to main content

Table 1 Respondent characteristics

From: Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation

Characteristic Frequency (%)
Number of respondents 25
Role
 Medical oncologist 16 (64%)
 Oncology pharmacist 9 (36%)
 Mean age, years (range) 41.2 (28–67)
Sex
 Male 11 (44%)
 Female 14 (56%)
Race
 Non-Hispanic White 18 (72%)
 Asian 7 (28%)
 Mean time in practice, years (range) a 10.2 (0.5–35)
Comfort with interpreting PGx test results
 Comfortable or very comfortable 15 (60%)
 Neutral 3 (12%)
 Uncomfortable or very uncomfortable 7 (28%)
Comfort with using PGx test results to guide chemotherapy dosing
 Comfortable or very comfortable 14 (56%)
 Neutral 4 (16%)
 Uncomfortable or very uncomfortable 7 (28%)
 Mean interview duration, minutes (range) 30.3 (23–41)
Interview modality
 In-person 14 (56%)
 Telephone 11 (44%)